Resmed Inc’s filing revealed that its Chief Executive Officer Farrell Michael J. unloaded Company’s shares for reported $2.27 million on Oct 07 ’25. In the deal valued at $282.85 per share,8,009 shares were sold. As a result of this transaction, Farrell Michael J. now holds 467,792 shares worth roughly $127.71 million.
Then, Farrell Michael J. bought 8,009 shares, generating $2,265,332 in total proceeds.
Before that, Ghoshal Kaushik bought 4,876 shares. Resmed Inc shares valued at $1,381,956 were divested by the Former Officer at a price of $283.42 per share.
Citigroup initiated its Resmed Inc [RMD] rating to a Buy in a research note published on September 18, 2025; the price target was $330. A number of analysts have revised their coverage, including CLSA’s analysts, who increased its forecast for the stock in early September from “a Hold” to “an Outperform”. RBC Capital Mkts also remained covering RMD and has increased its forecast on July 15, 2025 with a “an Outperform” recommendation from previously “Sector perform” rating. Morgan Stanley started covering the stock on March 19, 2025. It rated RMD as “an Overweight”.
Price Performance Review of RMD
On Monday, Resmed Inc [NYSE:RMD] saw its stock jump 0.37% to $273.01. Over the last five days, the stock has lost -2.97%. Resmed Inc shares have risen nearly 15.17% since the year began. Nevertheless, the stocks have risen 19.38% over the past one year.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-09-30, growing by 0.3 million shares to a total of 8.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 8.51 million shares. There was a rise of 3.35%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 19, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating.
